Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction

Cell Cycle

Volumn 10, Issue 7, 2011, Pages 1132-1143

  Tanowitz, Herbert B ^a   Mukhopadhyay, Aparna ^a   Ashton, Anthony W ^b   Lisanti, Michael P ^c   Machado, Fabiana S ^d   Weiss, Louis M ^a   Mukherjee, Shankar ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chagel disease; Microarray; Suppressor of cytokine signaling; Thromboxane signaling; Trypanosoma cruzi

Indexed keywords

JANUS KINASE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING; THROMBOXANE A2; THROMBOXANE RECEPTOR; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; INTRACELLULAR SIGNALING; MALE; MAMMAL CELL; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; TRYPANOSOMA CRUZI;

MAMMALIA; MUS; RATTUS; TRYPANOSOMA CRUZI;

EID: 79953661972     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.7.15207     Document Type: Article

References (39)

1. Haeggström JZ, Rinaldo-Matthis A, Wheelock CE, Wetterholm A. Advances in eicosanoid research, novel therapeutic implications. Biochem Biophys Res Commun 2010; 396:135-9.
2. Noverr MC, Erb-Downward JR, Huffnagle GB. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 2003; 16:517-33. (Pubitemid 36871319)
3. Belley A, Chadee K. Eicosanoid production by parasites: from pathogenesis to immunomodulation. Parasitol Today 1995; 11:327-34.
4. Kilunga Kubata B, Eguchi N, Urade Y, Yamashita K, Mitamura T, Tai K, et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic and immunosuppressive substances in humans. J Exp Med 1998; 88:1197-202. (Pubitemid 28443343)
5. 2α synthase in Trypanosoma brucei. J Exp Med 2000; 192:1327-38.
6. Liu LX, Weller PF. Arachidonic acid metabolism in filaria parasites. Exp Parasitol 1990; 71:496-501. (Pubitemid 20372367)
7. Tanowitz HB, Kirchhoff V, Simon D, Morris SA, Weiss LM, Wittner M. Chagas' disease. Clin Microbiol Rev 1992; 5:400-19.
8. Cantarovich F, Vazquez M, Garcia WD, Abbud Filho M, Herrera C, Villegas Hernandez A. Special infections in organ transplantation in South America. Transplant Proc 1992; 24:1902-8.
9. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RF. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42:549-55.
10. Cantarovich F, Vazquez M, Garcia WD, Abbud Filho M, Herrera C, Villegas Hernandez A. Special infections in organ transplantation in South America. Transplant Proc 1992; 24:1902-8.
11. Pereira KS, Schmidt FL, Barbosa RL, Guaraldo AM, Franco RM, Dias VL, Passos LA. Transmission of Chagas disease (American trypanosomiasis) by food. Adv Food Nutr Res 2010; 59:63-85.
12. Vaidian AK, Weiss LM, Tanowitz HB. Chagas' disease and AIDS. Kinetoplastid Biol Dis 2004; 3:2.
13. Ferreira D, Cortez M, Atayde VD, Yoshida N. Actin cytoskeleton-dependent and -independent host cell invasion by Trypanosoma cruzi is mediated by distinct parasite surface molecules. Infect Immun 2006; 74:5522-8. (Pubitemid 44484535)
14. Huang H, Chan J, Wittner M, Jelicks LA, Morris SA, Factor SM, et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 1999; 31:75-88. (Pubitemid 29078220)
15. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002; 18:262-5. (Pubitemid 34569236)
16. Petkova SB, Huang H, Factor SM, Pestell RG, Bouzahzah B, Jelicks LA, et al. The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 2001; 31:499-511. (Pubitemid 32382048)
17. Petkova SB, Tanowitz HB, Magazine HI, Factor SM, Chan J, Pestell RJ, et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol 2000; 9:257-65.
18. Huang H, Calderon TM, Berman JW, Braunstein VL, Weiss LM, Wittner M, et al. Infection of endothelial cells with Trypanosoma cruzi activates NFκB and induces vascular adhesion molecule expression. Infect Immun 1999; 67:5434-40. (Pubitemid 29455322)
19. Durand JL, Mukherjee S, Commodari F, De Souza AP, Zhao D, Machado FS, et al. Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice. Am J Trop Med Hyg 2009; 80:782-7.
20. 2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 2008; 118:18-35.
21. Tanowitz HB, Burns ER, Sinha AK, Kahn NN, Morris SA, Factor SM, et al. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am J Trop Med Hyg 1990; 43:274-81. (Pubitemid 20348454)
22. 2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med 2007; 204:929-40.
23. Ashton AW, Ware GM, Kaul DK, Ware JA. Inhibition of tumor necrosis factor α-mediated NFκB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G protein-linked receptor (TP) ligands. J Biol Chem 2003; 278:11858-66. (Pubitemid 36800156)
24. 2. Circ Res 2000; 87:739-45.
25. Bao Y, Weiss LM, Ma YF, Lisanti MP, Tanowitz HB, Das BC, et al. Molecular cloning and characterization of mitogen-activated protein kinase 2 in Trypanosoma cruzi. Cell Cycle 2010; 9:2888-96.
26. Mukherjee S, Nagajyothi F, Mukhopadhyay A, Machado FS, Belbin TJ, Campos de Carvalho A, et al. Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics 2008; 91:423-32.
27. Mukherjee S, Belbin TJ, Spray DC, Iacobas DA, Weiss LM, Kitsis RN, et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res 2003; 91:187-96. (Pubitemid 37260442)
28. Soares MB, de Lima RS, Rocha LL, Vasconcelos JF, Rogatto SR, dos Santos RR, et al. Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J Infect Dis 2010; 202:416-26.
29. Goldenberg RC, Iacobas DA, Iacobas S, Rocha LL, da Silva de Azevedo Fortes F, Vairo L, et al. Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 2009; 11:1140-9.
30. Adesse D, Iacobas DA, Iacobas S, Garzoni LR, Meirelles Mde N, Tanowitz HB, et al. Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi. Am J Trop Med Hyg 2010; 82:846-54.
31. Imai K, Mimori T, Kawai M, Koga H. Microarray analysis of host gene-expression during intracellular nests formation of Trypanosoma cruzi amastigotes. Microbiol Immunol 2005; 49:623-31. (Pubitemid 41289348)
32. Moore-Lai D, Rowland E. Microarray data demonstrate that Trypanosoma cruzi downregulates the expression of apoptotic genes in BALB/c fibroblasts. J Parasitol 2004; 90:893-5. (Pubitemid 39128760)
33. Shigihara T, Hashimoto M, Shindo N, Aoki T. Transcriptome profile of Trypanosoma cruzi-infected cells: simultaneous up and downregulation of proliferation inhibitors and promoters. Parasitol Res 2008; 102:715-22.
34. Nde PN, Johnson CA, Pratap S, Cardenas TC, Kleshchenko YY, Furtak VA, et al. Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand. Chem Biodivers 2010; 7:1051-64.
35. Geraghty P, Greene CM, O'Mahony M, O'Neill SJ, Taggart CC, McElvaney NG. Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression. J Biol Chem 2007; 282:33389-95. (Pubitemid 350159551)
36. Doumas S, Kolokotronis A, Stefanopoulos P. Antiinflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun 2005; 73:1271-4. (Pubitemid 40470711)
37. Garg N, Popov VL, Papaconstantinou J. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim Biophys Acta 2003; 1638:106-20. (Pubitemid 36829268)
38. Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, Prado CM, et al. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One; 2011; 6:e16959.
39. Mukherjee S, Huang H, Petkova SB, Albanese C, Pestell RG, Braunstein VL, et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun 2004; 72:5274-82. (Pubitemid 39223414)